Table 5. Association between CAT and modified DECAF Scores with clinical outcomes in acute exacerbation of COPD patients (N=120).

^*Fisher's exact test was used and statistically significant at p-value less than 0.05

CAT: COPD Assessment Test; DECAF; Dyspnea, Eosinopenia, Consolidation, Acidemia, and Atrial Fibrillation

CAT and modified DECAF scores versus clinical outcomes		Outcome		Fischer’s exact value	p-value
		Cured (n = 98)	Dead (n = 22)
CAT score	< 10 (n = 44)	35 (79.54%)	9 (20.45%)	1.492	0.474
	10 to 20 (n = 46)	40 (86.95%)	6 (13.04%)
	> 20 (n = 30)	23 (76.66%)	7 (23.33%)
Modified DECAF score	Low risk (n = 70)	70 (100%)	0 (0%)	84.532	0.001*
	Intermediate risk (n = 21)	21 (100%)	0 (0%)
	High risk (n = 29)	7 (24.13%)	22 (75.86%)